Data Insights
No filters selected
No filters selected
No filters selected
No filters selected
Belrestotug by ITeos Therapeutics for Squamous Non-Small Cell Lung Cancer: Likelihood of Approval
Belrestotug is under clinical development by ITeos Therapeutics and currently in Phase II for Squamous Non-Small Cell Lung Cancer. According...
Belrestotug by ITeos Therapeutics for Non-Small Cell Lung Cancer: Likelihood of Approval
Belrestotug is under clinical development by ITeos Therapeutics and currently in Phase II for Non-Small Cell Lung Cancer. According to...
EOS-984 by ITeos Therapeutics for Solid Tumor: Likelihood of Approval
EOS-984 is under clinical development by ITeos Therapeutics and currently in Phase I for Solid Tumor. According to GlobalData, Phase...